11-12 September 2024
AstraZeneca Discovery Centre
Cambridge, United Kingdom
11-12 September 2024
AstraZeneca Discovery Centre
Cambridge, United Kingdom
Microfluidics Technologies
Organ-specific Expression Data Steer Choice of Laminin for In Vitro Studies in Biologically Relevant Drug Discovery and Development Platforms
Sam Hobson, Ph.D. (BioLamina)
Miniaturization for Screening Applications
PhaseScan: A High-Throughput Microfluidic Platform for Biomolecular Condensate Analysis and Drug Discovery
Tadas Kartanas, Ph.D. (Transition Bio)
Miniaturization for Screening Applications
Powering up 3D Patient-derived Organoids: An Integrated, Multidisciplinary CRISPR Organoid Platform for Target and Drug Discovery in Oncology
Simon Vyse, Ph.D. (AstraZeneca)